Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 
DECN XPRIZE Testing Data for Rapid COVID-19 Testing Technology Yields Near Textbook Results
Data using XPRIZE supplied contrived fluid samples provides results comparable to those seen in the FDA lab testing of donor...
StageZero Life Sciences Provides Operational Update
TORONTO, ON / ACCESSWIRE / November 23, 2020 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company") announced today...
Kenergy Scientific INC. (KNSC) Has Changed Its Name to MedSmart Group Inc., and Has Done a Reverse Stock Split Effective November 23, 2020
BAY HARBOR ISLANDS, FL / ACCESSWIRE / November 23, 2020 / Kenergy Scientific, Inc. (OTC PINK:KNSCD) today announced that FINRA...
CordovaCann Granted Marijuana Production License in Oregon
TORONTO, ON / ACCESSWIRE / November 23, 2020 / CordovaCann Corp. (CSE:CDVA) (OTCQB:LVRLF) ("Cordova" or the "Company"), a cannabis-focused consumer...
Megola Product Lines May Help Combat COVID-19 Virus and Boost Mental Health
Two Unique Product lines offering Solutions for Consumers: Stink Genie Ozone Surface/Air Disinfectant and Balanced2Day (B2D) for Health and Wellness...
Perimeter Medical Imaging AI Announces Third Quarter 2020 Financial Results
TORONTO, ON / ACCESSWIRE / November 23, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC) ("Perimeter" or the "Company"), a medical technology...
Sparta Group’s ERS-International Division Helping Electronics Manufacturers/Importers Cope with New Ontario E-Waste Regulations
TORONTO, ON / ACCESSWIRE / November 23, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital"...
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
HERZLIYA, ISRAEL / ACCESSWIRE / November 23, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical...
Theralase Granted FDA Fast Track Designation for NMIBC Phase II Clinical Study
TORONTO, ON / ACCESSWIRE / November 23, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical...
Leafbuyer Technologies Announces Growth Strategy Into New Legalized Markets
Company Will Gain Recurring Revenue from Dispensaries in New Jersey, Arizona, and Other Legalized States DENVER, CO / ACCESSWIRE /...
SR Scales Expands Touchless Weighing Options
Stand-on Scales Feature Always-on Power Supply and Microban® Antimicrobial Product Protection TONAWANDA, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- SR...
Surgalign Holdings, Inc. Appoints Paul Lewicki, PhD to Board of Directors
DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on...
Akouos to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
BOSTON, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing...
Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials
BOSTON and DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development...
AgraFlora’s Delta Greenhouse Receives Agriculture Loan
Figure 1 Delta, BC. AgraFlora Greenhouse VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or...
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 23 November 2020 – On 3 November 2020, Novo Nordisk initiated a share repurchase programme in accordance with...
Cannabix Technologies to Beta Test Marijuana Breathalyzer with Occupational Health Clinic in Southern California to Meet Workplace Drug Testing Needs
Cannabix is developing the Cannabix Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety...
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Development addresses need for treatments for patients hospitalized with...
Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
WARREN, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2020 Earnings Conference Call at 8:00 am ET on November 30, 2020
Shenzhen, China, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a...